Show Summary Details
Page of

Pharmacological approaches to depression 

Pharmacological approaches to depression
Chapter:
Pharmacological approaches to depression
Author(s):

Roger S. McIntyre

and Jay Nathanson

DOI:
10.1093/med/9780199570249.003.0007
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 October 2019

Tricyclic antidepressants have been the conventional standard of efficacy in severe depression

Conventional pharmacotherapy (e.g., second- and later- generation antidepressants) offer efficacy in the treatment of MDD

Placebo response rates in severe depression have been consistently lower when compared to mild-moderate depression

The majority of individuals with severe depression will not achieve and/or sustain remission with antidepressant monotherapy

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.